0 CHECKOUT

Typhoid Fever - Pipeline Review, H2 2015

  • ID: 3384926
  • July 2015
  • 49 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline Plc
  • Prokarium Limited
  • Protein Potential, LLC
  • USV Limited
  • MORE

Typhoid Fever - Pipeline Review, H2 2015

Summary

The report ‘Typhoid Fever - Pipeline Review, H2 2015’, provides an overview of the Typhoid Fever’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Typhoid Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Typhoid Fever and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline Plc
  • Prokarium Limited
  • Protein Potential, LLC
  • USV Limited
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Typhoid Fever Overview
Therapeutics Development
Pipeline Products for Typhoid Fever - Overview
Pipeline Products for Typhoid Fever - Comparative Analysis
Typhoid Fever - Therapeutics under Development by Companies
Typhoid Fever - Therapeutics under Investigation by Universities/Institutes
Typhoid Fever - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Typhoid Fever - Products under Development by Companies
Typhoid Fever - Products under Investigation by Universities/Institutes
Typhoid Fever - Companies Involved in Therapeutics Development
Chongqing Zhifei Biological Products Co., Ltd.
GlaxoSmithKline Plc
Prokarium Limited
Protein Potential, LLC
Shantha Biotechnics Limited
USV Limited
Zydus Cadila Healthcare Limited
Typhoid Fever - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(typhoid fever + shigellosis) multivalent vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Typhella - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Typhetec - Drug Profile
Product Description
Mechanism of Action
R&D Progress
typhoid + paratyphoid (bivalent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
typhoid + paratyphoid vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
typhoid + pneumococcal vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
typhoid and paratyphoid fever vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
typhoid fever polysaccharide vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
typhoid vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ViCRM-197 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Typhoid Fever - Recent Pipeline Updates
Typhoid Fever - Dormant Projects
Typhoid Fever - Discontinued Products
Typhoid Fever - Product Development Milestones
Featured News & Press Releases
Mar 11, 2013: Prokarium And University Of Birmingham Receive £0.4m Grant To Develop Next Generation Vaccines
Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine
Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine
Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Typhoid Fever, H2 2015
Number of Products under Development for Typhoid Fever - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Typhoid Fever - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H2 2015
Typhoid Fever - Pipeline by GlaxoSmithKline Plc, H2 2015
Typhoid Fever - Pipeline by Prokarium Limited, H2 2015
Typhoid Fever - Pipeline by Protein Potential, LLC, H2 2015
Typhoid Fever - Pipeline by Shantha Biotechnics Limited, H2 2015
Typhoid Fever - Pipeline by USV Limited, H2 2015
Typhoid Fever - Pipeline by Zydus Cadila Healthcare Limited, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Typhoid Fever Therapeutics - Recent Pipeline Updates, H2 2015
Typhoid Fever - Dormant Projects, H2 2015
Typhoid Fever - Discontinued Products, H2 2015

List of Figures
Number of Products under Development for Typhoid Fever, H2 2015
Number of Products under Development for Typhoid Fever - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Assessment by Combination Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

Chongqing Zhifei Biological Products Co., Ltd.
GlaxoSmithKline Plc
Prokarium Limited
Protein Potential, LLC
Shantha Biotechnics Limited
USV Limited
Zydus Cadila Healthcare Limited

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Maquet Getinge Group
  • Emergent BioSolutions, Inc.
  • Aicuris GmbH & Co.KG
  • Merck & Co., Inc.